Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Nicotine is a chemical found mainly in tobacco plants and is also made in laboratories. It is the substance that causes addiction to tobacco products like cigarettes, cigars, and smokeless tobacco. When nicotine enters the body, it affects the brain and heart, increasing heart rate and creating feelings of relaxation or alertness. Nicotine itself is not a cancer-causing agent, but tobacco products containing nicotine cause many types of cancer and other serious health problems.
Nicotine often comes up in cancer care because many patients have used or currently use tobacco products. Quitting smoking or other tobacco use is one of the most important steps to improve health and treatment outcomes. Nicotine replacement therapies (NRTs), such as gum, patches, or inhalers, are tools that can help people stop smoking by reducing withdrawal symptoms and cravings. Some patients may also explore nicotine for symptom relief or supportive care, but nicotine is not an approved treatment for cancer itself. Using nicotine during cancer treatment requires careful discussion with healthcare providers because it can affect heart health, blood pressure, and interact with other medications or treatments.
Patients may hear about nicotine when discussing smoking cessation plans, supportive care options, or when reviewing medication lists. Nicotine replacement products are often recommended to help quit smoking safely. Patients might also encounter discussions about nicotine in relation to symptoms like fatigue, appetite changes, or cognitive effects, though these uses are not established cancer treatments. It is important to understand that nicotine addiction can make quitting tobacco difficult, and secondhand smoke from tobacco also harms others, including family members and children.
Nicotine may be mentioned in medical records, treatment plans, or during clinic visits when tobacco use or quitting strategies are discussed. It can also appear in patient education materials about quitting smoking or managing withdrawal symptoms. Nicotine replacement therapies are sometimes prescribed or recommended as part of a quitting plan. Patients may also see nicotine referenced in clinical trials or integrative oncology discussions exploring supportive care approaches.
Nicotine is not a cancer treatment or cure. It does not kill cancer cells or prevent cancer growth. While some people may explore nicotine for symptom relief or other reasons, these uses are not supported by strong scientific evidence. Nicotine use carries risks, including effects on heart rate, blood pressure, and the potential for addiction. Using nicotine products without medical advice during cancer treatment can be unsafe, especially if combined with surgery, chemotherapy, radiation, or other medications.
Because nicotine affects the heart and blood vessels and can interact with many cancer treatments, anyone considering nicotine use during cancer care should talk with their healthcare team. This is especially important if the patient is undergoing surgery, chemotherapy, radiation, immunotherapy, or taking medications like blood thinners or diabetes drugs. Nicotine replacement therapies are designed to help people quit smoking by delivering controlled doses of nicotine, which are generally safer than tobacco products but still require medical guidance. Avoiding tobacco and quitting smoking remain top priorities for health and cancer treatment success.
If you or a loved one is using tobacco or nicotine products during cancer care, talk openly with your healthcare team. Ask about safe ways to quit smoking, options for nicotine replacement therapy, and how nicotine use might affect your treatment and recovery. Remember that quitting tobacco can improve treatment outcomes and quality of life. Your care team can help create a plan that fits your needs and supports your health goals.
Public source information used for this glossary entry includes: